Delivery Order SPE2DB25D3201-SPE2DB25FNQCS
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,526.21, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,559,016,525 units of the drug Ondansetron HCl 8 mg tablets. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,160.68, is a delivery order for the supply of 4,566,769,850 units of the drug ondansetron hydrochloride 8 mg tablets. The contract has a firm fixed price and an ultimate completion date of December 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,666.91 firm-fixed-price delivery order is for the supply of 4566868388 - Ondansetron HCL 8 mg tablets, with a completion date of January 9, 2025.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,194.07 firm fixed-price delivery order is for the supply of 4,559,929,808 units of Ondansetron HCL 8 mg tablets, with a completion date of February 14, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $2,068.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,598,427 units of the medication Ondansetron ODT 8 mg Tablet, with a completion date of December 4, 2024. The contract is structured as a firm-fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,377.65 firm-fixed-price delivery order is for the supply of 4,565,219,948 units of the medication Ondansetron HCL 8 mg tablets. The contract has an ultimate completion date of July 23, 2024 and was awarded on July 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $9,996.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,134,913 units of Ondansetron ODT 4 mg Tablets in 30-count packages. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,786.82 Firm Fixed Price Delivery Order is for the supply of Ondansetron HCL 8 mg tablets. The contract has an ultimate completion date of November 5, 2024 and was awarded on November 4, 2024. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This federal contract award is for the delivery of 4,565,470,676 units of Ondansetron HCL 8 mg tablets by Amerisourcebergen Drug Corp to the U.S. government. The contract, valued at $7,519.33, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued up to $999,999,999 through December 2025, enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,540.12 firm fixed-price delivery order covers the supply of 4,566,628,304 units of Ondansetron HCL 8 mg tablets. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...